在乳腺癌中解码Hippo信号通路组件的基因表达特征
Hunayna M Bhavnagari1,2, Franky D Shah3
1Life Science Department, Gujarat University, Ahmedabad, Gujarat, India.
Molecular biology reports
|February 10, 2025
概括
对于细胞调节至关重要的Hippo信号通路在乳腺癌中是下调的,这表明它的瘤抑制作用. 这一发现突出了该途径的路径.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞信号传递 细胞信号传递
背景情况:
- 河马信号通路是器官大小,茎状和组织平衡的进化保守调节器.
- 河马通路的放松调节与瘤发生有关,但其在乳腺癌中的作用仍未得到充分研究.
- 这种途径作为关键的瘤抑制机制起作用.
研究的目的:
- 为了研究河马信号通路在乳腺癌中的作用.
- 分析乳腺癌组织中Hippo通路分子的表达.
- 为了将基因表达与临床病理参数相关联.
主要方法:
- 定量实时PCR用于评估120名治疗前乳腺癌患者10个核心Hippo途径分子的mRNA表达.
- 统计分析包括对对样本t测试,皮尔森奇方测试和ROC曲线分析.
- 基因表达在恶性和相邻的正常乳腺组织之间进行了比较.
主要成果:
- 与正常组织相比,所有10个核心Hippo信号通路分子 (SAV1,MOB1A,MOB1B,MST1,MST2,LATS1,LATS2,YAP,TAZ,TEAD1) 在恶性乳腺组织中都被显著下调.
- LATS1,MST1和SAV1与乳腺癌阶段有显著的负相关性,而MOB1B与乳腺癌阶段有积极相关性.
- 接收器操作特征 (ROC) 曲线分析表明,对于YAP,TAZ,LATS2和TEAD,恶性和正常组织之间存在显著的歧视.
结论:
- 乳腺癌中Hippo信号通路分子 (YAP,TAZ,LATS1,LATS2,MST1,MST2,SAV1,MOB1,MOB1B,TEAD1) 的降低调节表明它的激活.
- 激活的Hippo通路似乎在乳腺癌的发展中起着重要的瘤抑制作用.
- 针对Hippo通路的进一步研究可能为乳腺癌提供新的治疗策略.
关键词:
乳腺癌 乳腺癌是什么?临床病理参数 临床病理参数河马信号通道的信号通道实时PCR可以实现.在TAZTAZ中,我们可以看到.哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈更多相关视频
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
6.7K
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
10.8K
相关概念视频
Hedgehog Signaling Pathway
7.3K
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.3K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
